|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
Articles |
Positron emission tomography (PET) is a nuclear imaging technique that can dynamically image trace amounts of positron-labeled radiopharmaceuticals in vivo. Tracer concentrations can be determined quantitatively, and by application of appropriate tracer kinetic models, the rates of a wide range of different biological processes can be measured noninvasively in humans. PET has been used as a research tool for more than 25 years and has also found clinical applications, particularly in oncology, neurological disorders, and cardiovascular disease. Recently, there has been tremendous interest in applying PET technology to in vivo small-animal imaging. Significant improvements in the imaging technology now permit a wide range of PET studies in mice and rats, using compact, relatively low-cost, dedicated small-animal PET scanners. This article reviews the fundamental basis of PET imaging and discusses the development of small-animal PET scanners and their possible application in preclinical drug development.
This article has been cited by other articles:
![]() |
W. E. Klunk, B. J. Lopresti, M. D. Ikonomovic, I. M. Lefterov, R. P. Koldamova, E. E. Abrahamson, M. L. Debnath, D. P. Holt, G.-f. Huang, L. Shao, et al. Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-{beta} in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain J. Neurosci., November 16, 2005; 25(46): 10598 - 10606. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Kelloff, J. M. Hoffman, B. Johnson, H. I. Scher, B. A. Siegel, E. Y. Cheng, B. D. Cheson, J. O'Shaughnessy, K. Z. Guyton, D. A. Mankoff, et al. Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development Clin. Cancer Res., April 15, 2005; 11(8): 2785 - 2808. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Abbey, A. D. Borowsky, E. T. McGoldrick, J. P. Gregg, J. E. Maglione, R. D. Cardiff, and S. R. Cherry In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia PNAS, August 3, 2004; 101(31): 11438 - 11443. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tashiro, Y. Sakurada, K. Iwabuchi, H. Mochizuki, M. Kato, M. Aoki, Y. Funaki, M. Itoh, R. Iwata, D. F. Wong, et al. Central Effects of Fexofenadine and Cetirizine: Measurement of Psychomotor Performance, Subjective Sleepiness, and Brain Histamine H1-Receptor Occupancy Using 11C-Doxepin Positron Emission Tomography J. Clin. Pharmacol., August 1, 2004; 44(8): 890 - 900. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |